# US 2019/0316163 A1 · Method for enhancing extracellular vesicle production

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0316163 A1
- Document ID: US20190316163A1
- Status: Published application
- Kind: A1
- Application number: 16/436,331
- Filed: 2019-06-10
- Published: 2019-10-17
- Earliest claimed: 2016-02-11
- Assignees: Research Foundation of the City University of New York; Japanese Foundation for Cancer Research
- Applicants: Research Foundation of the City University of New York; Japanese Foundation for Cancer Research
- Inventors: Hiroshi Matsui; Kiyotaka Shiba; Min A. Kang
- Web page: https://patentgrep.com/patent/US20190316163A1

## CPC

- A61K 47/46: Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
- C12P 21/00: Preparation of peptides or proteins (single cell protein C12N1/00)
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K 35/12: Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells (vaccines or medicinal preparations containing antigens or antibodies A61K39/00)
- A61K 35/13: Tumour cells, irrespective of tissue of origin (tumour vaccines A61K39/00)
- C07K 5/06078: {and aromatic or cycloaliphatic}
- C07K 5/0812: {and aromatic or cycloaliphatic}
- C07K 5/1016: {and aromatic or cycloaliphatic}
- C07K 5/1027: {containing heteroatoms different from O, S, or N}
- C07K 7/06: having 5 to 11 amino acids
- C07K 7/08: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
- C12N 5/0006: {Modification of the membrane of cells, e.g. cell decoration}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A method for enhancing extracellular vesicle production is described. A peptide that induces polymer formation is incubated with a cell culture which results in enhanced EV production. The peptide penetrates the cells and subsequently polymerizes upon exposure to enzymes (e.g. phosphatase) within the cell. The cells that contain the newly formed polymers have an increased production of EVs. These EVs can be harvested using centrifugation techniques.

## Claims

### Claim 1

A method of enhanced extracellular vesicle production, the method comprising sequential steps of:
exposing a plurality of cells to a permeability-enhancing agent;
treating the plurality of cells with NapFFK(NDB)Yp at a concentration of at least 5 μM and less than 100 μM;
permitting the NapFFK(NDB)Yp to polymerize within cells in the plurality of cells due to an enzyme within the cells to form a modified cell culture; and
isolating a first quantity of extracellular vesicles from the modified cell culture, wherein the first quantity of extracellular vesicles is greater than a second quantity of extracellular vesicles isolated from a corresponding plurality of cells that was not treated with the NapFFK(NDB)Yp.

### Claim 2 (depends on 1)

The method as recited in claim 1, wherein the step of isolating occurs between 20 minutes and 60 minutes of the step of treating.

### Claim 3 (depends on 1)

The method as recited in claim 1, wherein the enzyme is a phosphatase enzyme.

### Claim 4 (depends on 1)

The method as recited in claim 1, wherein the permeability-enhancing agent is an octylphenol ethoxylate surfactant.

### Claim 5 (depends on 1)

The method as recited in claim 1, wherein the permeability-enhancing agent is a saponin.

### Claim 6 (depends on 1)

The method as recited in claim 1, wherein the permeability-enhancing agent is sodium dodecyl sulfate (SDS).

### Claim 7 (depends on 1)

The method as recited in claim 1, wherein the permeability-enhancing agent is an octylphenol ethoxylate surfactant.

### Claim 8 (depends on 1)

The method as recited in claim 1, wherein the permeability-enhancing agent is a saponin.

### Claim 9 (depends on 1)

The method as recited in claim 1, wherein the first quantity of extracellular vesicles is at least 50% greater than the second quantity.

### Claim 10

A method of enhanced extracellular vesicle production, the method comprising sequential steps of:
exposing a plurality of cells to a permeability-enhancing agent;
treating the plurality of cells with NapFFK(NDB)Yp at a concentration of at least 5 μM and less than 100 μM;
permitting the NapFFK(NDB)Yp to polymerize within cells in the plurality of cells due to a phosphatase enzyme within the cells to form a modified cell culture; and
isolating a first quantity of extracellular vesicles from the modified cell culture, wherein the first quantity of extracellular vesicles is greater than a second quantity of extracellular vesicles isolated from a corresponding plurality of cells that was not treated with the NapFFK(NDB)Yp;
wherein the step of isolating occurs between 20 minutes and 60 minutes of the step of treating.
